PolyPid PYPD 深 滬
等待開盤 10-28 09:30:00 美东时间
5.77
+0.480
+9.07%
華盛通- 最 高5.79
- 今 開5.34
- 成交量 22.91万股
- 最 低 5.34
- 昨 收 5.29
- 總市值 1.17亿
- 52周最高 5.79
- 市盈率 靜 --
- 換手率 1.13%
- 52周最低 3.50
- 委 比 -26.20%
- 總股本 2031.18万
- 歷史最高 583.50
- 量 比 1.90
- 振 幅 8.51%
- 歷史最低 2.30
- 每 手 1
- 風險率 0.49%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅94.81%！富瑞上调ArriVent BioPharma(AVBP)目标价至30美元，维持"买入"评级
今日重点评级关注：富瑞：维持ArriVent BioPharma"买入"评级，目标价从18美元升至30美元；古根海姆：维持第一太阳能"买入"评级，目标价从282美元升至299美元
今天 12:30
PolyPid收涨9.07%，成交额128.82万美元
10月28日，PolyPid（PYPD）收涨9.07%，报5.77美元，成交额128.82万美元，市值1.17亿美元。 行情数据 • 开盘价：5.34美元 •...
今天 06:58
Oppenheimer Initiates Coverage On PolyPid with Outperform Rating, Announces Price Target of $10
Oppenheimer analyst Les Sulewski initiates coverage on PolyPid (NASDAQ:PYPD) with a Outperform rating and announces Price Target of $10.
10-27 18:52
PolyPid to Present D-PLEX₁₀₀ Microbiology Data at IDWeek 2026
PolyPid Ltd. announced at IDWeek 2026 that its D-PLEX₁₀₀ treatment showed lower bacterial burden and delayed onset of surgical-site infections (SSIs) compared to standard care, without increasing multidrug-resistant organisms. The exploratory analysis from 2,185 patients across three trials highlighted a 60% relative risk reduction in SSIs and favorable microbiological outcomes, supporting its potential in combating antimicrobial resistance.
10-21 12:00
PolyPid收涨3.39%，成交额54.46万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-20 07:08
PolyPid收跌3.67%，成交额72.04万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 07:08
PolyPid’s D-PLEX₁₀₀ Application Validated by EMA, Advancing Dual EU–U.S. Reviews
PolyPid ( ($PYPD) ) has shared an announcement. PolyPid announced on October 1,...
10-01 21:48
PolyPid Agrees With ADVANZ PHARMA To Terminate Their 2022 Exclusive License, Distribution And Supply Agreement For D-PLEX₁₀₀ In Europe
As a result, the exclusive European commercialization rights for D-PLEX₁₀₀ have reverted to PolyPid.
10-01 21:11
Analysts Are Bullish on These Healthcare Stocks: PolyPid (PYPD), Equillium (EQ)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
08-14 10:30
PolyPid (PYPD) 2026年第二季度业绩电话会议：D-PLEX100优先审评与Azurity交易
PolyPid 2026财年第二季度业绩电话会议涵盖了D-PLEX100优先审评、11月PDUFA日期、与Azurity的交易、净亏损收窄以及可支撑至2028年的现金储备。
08-14 08:35
